Macquarie Group’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-308
Closed -$20K 1662
2024
Q3
$20K Sell
308
-438,022
-100% -$31.6M ﹤0.01% 1611
2024
Q2
$29.6M Buy
438,330
+59,571
+16% +$4.16M 0.03% 570
2024
Q1
$30M Sell
378,759
-26,850
-7% -$2.2M 0.03% 586
2023
Q4
$31.5M Sell
405,609
-36,940
-8% -$2.73M 0.04% 573
2023
Q3
$31.1M Sell
442,549
-76,507
-15% -$5.72M 0.04% 546
2023
Q2
$41.3M Buy
519,056
+25,570
+5% +$1.85M 0.05% 488
2023
Q1
$35.7M Buy
493,486
+440,221
+826% +$34.3M 0.04% 529
2022
Q4
$4.38M Sell
53,265
-263,745
-83% -$21.7M 0.01% 1010
2022
Q3
$24.9M Buy
317,010
+219,734
+226% +$17.6M 0.03% 633
2022
Q2
$6.58M Buy
97,276
+95,444
+5,210% +$6.66M 0.01% 969
2022
Q1
$120 Sell
1,832
-1,758
-49% -$102K ﹤0.01% 1904
2021
Q4
$218K Buy
3,590
+58
+2% +$3.46K ﹤0.01% 1745
2021
Q3
$225K Sell
3,532
-355
-9% -$22.4K ﹤0.01% 1784
2021
Q2
$244K Sell
3,887
-1,211
-24% -$75.9K ﹤0.01% 1771
2021
Q1
$291K Sell
5,098
-1,133
-18% -$61.3K ﹤0.01% 1623
2020
Q4
$313K Sell
6,231
-985
-14% -$39.3K ﹤0.01% 1549
2020
Q3
$213K Sell
7,216
-346
-5% -$10K ﹤0.01% 1597
2020
Q2
$190K Buy
7,562
+2,940
+64% +$73.4K ﹤0.01% 1561
2020
Q1
$85K Sell
4,622
-2,931
-39% -$83.9K ﹤0.01% 1675
2019
Q4
$251K Buy
+7,553
New +$237K ﹤0.01% 1541
2018
Q1
Sell
-37,540
Closed -$1.23M 2150
2017
Q4
$1.23M Buy
37,540
+16,540
+79% +$573K ﹤0.01% 1187
2017
Q3
$1M Buy
+21,000
New +$1.02M ﹤0.01% 1209
2017
Q2
Sell
-43,290
Closed -$1.89M 1520
2017
Q1
$1.89M Sell
43,290
-39,990
-48% -$1.62M ﹤0.01% 991
2016
Q4
$2.76M Buy
83,280
+52,690
+172% +$2.04M 0.01% 879
2016
Q3
$1.52M Sell
30,590
-62,678
-67% -$3.26M ﹤0.01% 1037
2016
Q2
$5.17M Sell
93,268
-4,277
-4% -$250K 0.01% 865
2016
Q1
$5.38M Buy
97,545
+51,827
+113% +$2.96M 0.01% 696
2015
Q4
$2.86M Sell
45,718
-772
-2% -$50.3K 0.01% 840
2015
Q3
$3.08M Sell
46,490
-10,145
-18% -$780K 0.01% 862
2015
Q2
$4.44M Sell
56,635
-7,752
-12% -$558K 0.01% 780
2015
Q1
$4.61M Buy
64,387
+7,335
+13% +$470K 0.01% 768
2014
Q4
$3.49M Sell
57,052
-9,445
-14% -$550K 0.01% 836
2014
Q3
$3.23M Hold
66,497
0.01% 845
2014
Q2
$3.03M Buy
66,497
+29,031
+77% +$1.28M 0.01% 883
2014
Q1
$1.69M Sell
37,466
-6,852
-15% -$338K ﹤0.01% 1059
2013
Q4
$2.1M Buy
44,318
+3,671
+9% +$160K ﹤0.01% 967
2013
Q3
$1.6M Buy
40,647
+2,370
+6% +$88K ﹤0.01% 1032
2013
Q2
$1.27M Buy
+38,277
New +$1.24M ﹤0.01% 1089

Other funds holding ACHC

Macquarie Group's ACHC Position: Q4 2024 in Review

Macquarie Group sold out of Acadia Healthcare (ACHC) in Q4 2024, closing a stake of 308 shares — an estimated $20K sold.

Macquarie Group first reported a position in ACHC in Q2 2013 and held it in 38 quarters. The position peaked at $41.3M in Q2 2023. 306 funds tracked by Wall St. Rank hold ACHC as of Q4 2024.

  • Macquarie Group reported no remaining Acadia Healthcare position as of Q4 2024 after selling out during the quarter.
  • Macquarie Group sold 308 Acadia Healthcare shares in Q4 2024, an estimated $20K.
  • Macquarie Group first reported a position in Acadia Healthcare in Q2 2013 and held it in 38 quarters.
  • Macquarie Group's Acadia Healthcare position peaked at $41.3M in Q2 2023.
  • 306 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2024.

Based on Macquarie Group's 13F filing for Q4 2024, filed 14 Feb 2025.